From First Down to Touchdown: CereScan Scores at Super Bowl 50’s Radio Row

From the time the CereScan team landed at San Francisco International Airport on the Tuesday of Super Bowl week until the moment Radio Row closed its doors, CereScan, along with some of the hardest hitters in the NFL, brought the company’s story of hope and healing to millions.

From brain injury awareness, personal battles, to the future of football, NFL star players Bill Romanowski, Ted Johnson, Spencer Tillman, and Tim Krumrie offered up their insights into how CereScan is helping elite athletes and others suffering from the effects of multiple head injuriesto Super Bowl 50’s Radio Row media outlets.

Read More: Tim Krumrie Talks Football’s Future, CereScan Technology 

The Super Bowl visit came shortly after an explosion of media stories and new research studies called attention to CereScan for its patented process that assists medical professionals in addressing the invisible nature and chronic problems associated with traumatic brain injuries.

For the Radio Row Super Bowl 50 media blitz CereScan was represented by:

Bill Romanowski Super Bowl 50 Bill Romanowski

A former NFL linebacker, Bill Romanowski played for the San Francisco 49ers, Philadelphia Eagles, Denver Broncos, and Oakland Raiders and won four Super Bowl Championships. Romanowski co-authored his New York Times best-selling autobiography and founded Nutrition 53, a nutritional supplement company.

Ted Johnson Super Bowl 50 Ted Johnson

During his 10-year professional football career, former New England Patriots linebacker Ted Johnson played in 125 regular season games and three Super Bowl championships. Currently Johnson serves as co-host of “The Triple Threat,” an afternoon sports radio show on KILT SportsRadio 610 in Houston.

Spencer Tillman Superbowl 50 Spencer Tillman

A former professional American football player turned journalist, Spencer Tillman played running back for eight seasons for the Houston Oilers and San Francisco 49ers. Tillman’s football and broadcasting careers developed in tandem. He is currently a Fox Sports football analyst and serves as president and CEO of Axiom Sports Productions, Inc.

Tim Krumrie Super Bowl 50 Tim Krumrie

Spending 27 years as an NFL player and a coach, Tim Krumrie has appeared in 193 career games, including five postseason starts and was a part of the Cincinnati Bengals’ Super Bowl XXIII squad, as well as a two-time AP All-Pro and a participant in two AFC Pro Bowls. Krumrie was recently inducted into the College Football of Fame and currently serves as CereScan’s Brain Injury Advocate.

John Kelley, CEO of CereScan John Kelley

Serving as CereScan’s Chairman and CEO, John Kelley has held several senior-leadership positions at top-performing technology companies. Kelley has also participated at the board level on several local and national nonprofit organizations. Additionally, he served in the U.S. Army (1970-1972) and played varsity baseball at the University of Missouri, Columbia.

The NFL alumni, along with CereScan’s CEO, also stressed to Radio Row media outlets the importance of an accurate diagnosis as the starting point to a better quality of life. Unlike MRI and CT scans, which are structural images of the brain, CereScan can pinpoint the actual area of the brain that is abnormally functioning, and provide a clear image for an accurate diagnosis and a better treatment path.

Radio Row plays a major role in the hype and promotion during the week leading up to the Super Bowl. For Super Bowl 50, Radio Row was set up in the Moscone Convention Center in San Francisco. It serves as place where sports talk radio stations from around the world set up remote operations and broadcast live as they interview current and former players, as well as celebrities and stars associated — or not associated — with the big game.

Read More: CereScan and NFL Alumni to Create Buzz During Super Bowl 50  

CereScan spoke to over 75 media outlets at Radio Row, and below are a few of our Super Bowl 50 media highlights:

Facebook Share

Twitter Share

CereScan Sponsors Wounded Warrior Amputees vs. NFL Stars Flag Football Game

CereScan caps off a week of media events prior to Super Bowl 50 by throwing its support to wounded veterans through the Wounded Warrior Amputee Football Team Game against NFL star players.

Big games come and go, but only one will showcase the bravery and perseverance of those who have sacrificed so much for our country. CereScan, a nationally recognized brain diagnostics and technology company, will join NFL alumni and celebrities as a key sponsor of The Wounded Warrior Amputee Football Team (WWAFT) vs. NFL Stars Flag Football Game on February 6, 2016.

The event, scheduled to kick off at 12 p.m. on Super Bowl Saturday at the College of San Mateo (CSM), is a key part of the festivities leading up to Super Bowl 50. The WWAFT game will match up veterans who have lost limbs in Afghanistan or Iraq with more than 40 NFL Alumni. The event will raise awareness for amputee veterans and active duty soldiers, while also giving the veterans the opportunity to showcase their athletic talents. Nowhere else in the Bay Area during Super Bowl week will you experience such a moving, heartfelt game than at CSM’s College Heights Stadium.

“CereScan is honored to support such a worthy event. It’s now our turn to serve the brave men and women who have sacrificed so much for our freedom,” said John Kelley, Chairman and CEO of CereScan Corp.

It’s easy to get excited about the NFL greats and celebrities that will take to the field. Pittsburgh Steelers four-time Super Bowl champion and Vietnam Veteran, Rocky Bleier, co-hosts the game with CSM and Niner’s alum, Bill Ring. In fact, the San Francisco Forty-Niners will be well represented throughout the game. Home team champions include Dan Bunz, Derrick Deese, Chris Draft, William Floyd, Bill Romanowski, Dana Stubblefield, and Spencer Tillman, while former Los Angeles Raider, Bob Golic, brings a bit of a rivalry to the field.

Read More: TBI and PTSD are Veterans Hidden Wounds 

Snoop Dogg and alumni from the Broncos, Browns, Colts, Eagles, Falcons, Rams, Packers, Patriots, and more will play alongside our local heroes. But, the moment of inspiration comes when the group of veterans, all amputees, face-off at the 50-yard line. These modern-day warriors will defend their team as bravely as they defended our country in combat.

CereScan, through its “Invisible Brain Injury Project”, in partnership with the Tug McGraw Foundation, has been leading the charge toward accurate diagnosis and treatment of chronic Traumatic Brain Injury in military members and veterans. The company recently announced its approval by TRICARE, the health care insurance provider of the United States Department of Defense Military Health System. TRICARE provides health benefits for active-duty military members, retirees, and their families. The WWAFT game, as a part of the largest media event worldwide, provides an ideal platform to increase awareness and generate support for the cause.

CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:

Get the answers you deserve and start your path to better health. Contact us today for a free consultation. 

CereScan Welcomes Dr. Stuart Stein to its Scientific and Medical Advisory Board

Scientific and Medical Advisory Board

CereScan Corp. adds noted Neurologist Stuart A. Stein, MD, MBA, MS to its Scientific and Medical Advisory Board, with plans for further additions in the near term.

The medical expertise on CereScan Corp’s Scientific and Medical Advisory Board has expanded with the addition of board certified Neurologist Stuart A. Stein, MD, MBA, MS. Dr. Stein will join current members, including (retired) Major General Gale Pollock, former Surgeon General of the U.S. Army, in advancing the company’s research, data and diagnostics development plans.

Dr. Stein brings 39 years of medical experience and his extensive medical research background to CereScan’s Scientific and Medical Advisory Board. He is an adult pediatric, and neonatal neurologist, a NIH fellowship- trained molecular biologist and Neurogeneticist, a translational informatician, a neurology department and regional chairman, a former scientific director of a large research institute, a specialist in animal models of human disease, and a stroke neurologist with a particular interest in acute care and prevention of stroke.

Dr. Stein’s expertise includes the development of regional neurology departments and centers and in complex clinical and research programs and departments that are both national and international; all of these have been built on a combination of basic and clinical research, high level clinical care, and sound business principles. Most recently, he served as Director of Neurology and Neurology Program and the Stroke Center for the Banner Health East Valley Phoenix Region, as well as multiple prior academic appointments.

He also has broad and extensive clinical experience in complex neurological disorders, including epilepsy, stroke, neuroimmunological disorders, neurogenetics, mitochondrial and metabolic disorders, neurocritical care, and neurology/neurosurgery interfaces. He has particular expertise in non-invasive brain and neck blood vessel imaging. He has had long-term NIH research funding for 22 years as a principal investigator and he has been awarded and managed large numbers of contracts and grants. His research has also been funded by multiple Foundations. He has directed and built multidisciplinary research groups and has been a Visiting Professor on multiple occasions.

Dr. Stein currently serves as the CEO, President, and Managing Partner of several companies. One of the companies is developing acute and preventative diagnostic modalities and systems that are rapid and point of care, for TBI and stroke diagnosis, to promote early, safe, and state of the art care. Another company is a preventative Stroke Neurogenomics company.

Dr. Stein has his BS from the University of Michigan and earned his medical degree from Northwestern University’s Feinberg School of Medicine, a MBA in Health Sector and Health Policy Management from the University of Miami, and a MS in Biomedical and Translational Informatics (Clinical Genomics) from Arizona State University at Mayo Clinic in Scottsdale, AZ.

“CereScan provides a unique and important set of imaging modalities predicated on the use of PET and SPECT technologies and on quality data analysis and informatics that provides additional diagnostic precision and potential more definitive and appropriate treatment of TBI, and specific psychiatric and neurological disorders,” said Dr. Stuart Stein.

“CereScan’s armamentarium of tools and already established applicability to TBI and specific brain disorder enhances and compliments standard brain imaging studies and neurological, neuropsychological and psychiatric evaluation for patient care,” Stein added. “The need for identification of brain imaging abnormalities and their specific brain localizations are particularly important for military patients, post TBI in combat, and for TBI related to contact athletics in children and adults for rational prevention and other therapies to improve long term prognosis.”

“Stuart Stein is a long-time friend and advocate of CereScan,” said John Kelley, Chairman and CEO of CereScan Corp. “We are certainly fortunate to have his brilliant and unique insight at our disposal as we embark on an ambitious plan for development in key areas of our business.”
CereScan, is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:

ABOUT CERESCAN

CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.

CereScan Corp. expands its intellectual property with the issuance of a new patent-Neuroimaging Database Systems and Methods

Littleton, CO December 11th, 2014

CereScan Corp. (cerescan.com), a state of the art brain imaging and analytics company, is transforming the modern understanding of brain science and neurodiagnostics by developing the country’s largest and most comprehensive data warehouse for analyzing functional brain images and patient clinical information. The United States Patent and Trademark Office recently issued a patent to CereScan for its techniques in analyzing brain conditions. The CereMetrix™ Brain Diagnostic System (BDS) is a brain imaging and diagnostic reference tool that changes the way medical professionals, research institutions, medical device manufacturers and pharmaceutical companies understand brain diagnostics and treatment worldwide. The CereMetrix™ BDS is a robust medical library which includes standard patient health records, coupled with radiological, neurological and psychological diagnoses. Currently, CereMetrix™ includes comprehensive data on thousands of patients with chronic neurological and complex neuropsychiatric conditions.

Each CereScan patient has a unique medical history and neurological makeup. After undergoing neuropsychological assessments and two separate functional brain scans providing quantitative data, the information is then processed and cataloged within the CereMetrix™ BDS along with the patient’s full medical history, clinical symptomology, and demographic information. By aggregating and integrating this valuable clinical information, the CereMetrix™ system can effectively identify combinations of clinical characteristics and perfusion (blood flow) patterns associated with specific chronic brain disorders.

The CereMetrix™ BDS includes hundreds of searchable data elements including each patient’s clinical history, family history, immunizations, presenting symptoms, prior diagnoses, medications and previous treatments, along with a library of high-definition, statistically mapped functional brain images analyzing up to 120 regions of the brain. Our patient records represent a broad spectrum of conditions such as traumatic brain injury (TBI), toxic brain injury, Alzheimer’s Disease and other dementias, bipolar disorder, attention deficit hyperactivity disorder (ADHD), anxiety, autism, depression and other brain disorders. As it continues to grow, the system will become an integrated database with increasingly precise data, and will provide a set of protocols designed to support research and diagnostic applications for patients suffering from chronic brain disorders.

The functional imaging patterns detected by the CereMetrix™ BDS, in conjunction with the aforementioned clinical information, allows doctors to more quickly and accurately diagnose chronic brain conditions, which will spark the development of new and innovative research opportunities, more effective treatment paths, and possible cures for debilitating neurological and neuropsychiatric conditions.

“The application of big data in a medical setting will enhance CereScan’s position as the industry leader in brain health and care,” stated John Kelley, Chief Executive Officer and Chairman of CereScan. “The medical community will be able to evaluate brain based disorders through cutting edge machine learning technology allowing for improved patient diagnosis and treatment.”

With each new patient, the CereMetrix™ BDS will ”learn” more and will further its position as the leading diagnostic tool in identifying and treating brain disorders. CereScan’s diagnostic system is continually being refined and enhanced to include sophisticated searching and reporting functionality that will eventually become the industry standard in effectively diagnosing brain related illnesses, becoming one of the most desired diagnostic tools utilized across the medical industry.

About CereScan
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technology with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. For clinical patients, CereScan helps them and their physicians better understand the biological basis of their conditions. For forensic cases, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit www.CereScan.com.